The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 123 results:
Author Title Type [ Year(Desc)]
Filters: Author is Tsapas, Apostolos  [Clear All Filters]
2017
Karagiannis, T., Bekiari E., & Tsapas A. (2017).  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy. Core Evidence. Volume 12, 1 - 10.
Karagiannis, T., Bekiari E., & Tsapas A. (2017).  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.. Core Evid. 12, 1-10.
Katsoula, A., Paschos P., Haidich A-B., Tsapas A., & Giouleme O. (2017).  Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer. JAMA Internal Medicine. 177(8), 1110.
Klonizakis, P., Klaassen R., Sousos N., Liakos A., Tsapas A., & Vlachaki E. (2017).  Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.. Ann Hematol. 96(11), 1937-1944.
Klonizakis, P., Klaassen R., Sousos N., Liakos A., Tsapas A., & Vlachaki E. (2017).  Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients. Annals of Hematology. 9635386959511886953716410511460363056271262012394215457(1111435131343Suppl 21151168618233445), 1937 - 1944.
Liakopoulou, P., Liakos A., Vasilakou D., Athanasiadou E., Bekiari E., Kazakos K., et al. (2017).  Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.. Endocrine. 56(3), 485-494.
Liakopoulou, P., Liakos A., Vasilakou D., Athanasiadou E., Bekiari E., Kazakos K., et al. (2017).  Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis. Endocrine. 5625815134372239371731583439396341596(31134341111109129114943), 485 - 494.
Bekiari, E., Karagiannis T., Haidich A-B., & Tsapas A. (2017).  Meta-analysis of artificial pancreas trials: methodological considerations. The Lancet Diabetes & Endocrinology. 5(9), 685.
Bekiari, E., Karagiannis T., Haidich A-B., & Tsapas A. (2017).  Meta-analysis of artificial pancreas trials: methodological considerations.. Lancet Diabetes Endocrinol. 5(9), 685.
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Expert Opinion on Pharmacotherapy. 18555857646565(9111111), 843 - 851.
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.. Expert Opin Pharmacother. 18(9), 843-851.
2018
Bekiari, E., Kitsios K., Thabit H., Tauschmann M., Athanasiadou E., Karagiannis T., et al. (2018).  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.. BMJ. 361, k1310.
Bekiari, E., Kitsios K., Thabit H., Tauschmann M., Athanasiadou E., Karagiannis T., et al. (2018).  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. k1310.
Gourzoulidis, G., Tzanetakos C., Ioannidis I., Tsapas A., Kourlaba G., Papageorgiou G., et al. (2018).  Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece. Clinical Drug Investigation. 3831184061314132015410373121437191919154637191436(511Suppl 2518942221193773988), 417 - 426.
Gourzoulidis, G., Tzanetakos C., Ioannidis I., Tsapas A., Kourlaba G., Papageorgiou G., et al. (2018).  Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.. Clin Drug Investig. 38(5), 417-426.
Bekiari, E., Karagiannis T., & Tsapas A. (2018).  In type 2 diabetes, weekly semaglutide reduced HbA 1c and increased weight loss more than weekly exenatide ER. Annals of Internal Medicine. 168(8), JC46.
Bekiari, E., Karagiannis T., & Tsapas A. (2018).  In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly exenatide ER.. Ann Intern Med. 168(8), JC46.
Bistola, V., Lambadiari V., Dimitriadis G., Ioannidis I., Makrilakis K., Tentolouris N., et al. (2018).  Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.. Heart Fail Rev. 23(3), 377-388.
Bistola, V., Lambadiari V., Dimitriadis G., Ioannidis I., Makrilakis K., Tentolouris N., et al. (2018).  Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors. Heart Failure Reviews. 377 - 388.
Bougioukas, K. I., Liakos A., Tsapas A., Ntzani E., & Haidich A-B. (2018).  Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms.. J Clin Epidemiol. 93, 9-24.
Bougioukas, K. I., Liakos A., Tsapas A., Ntzani E., & Haidich A-B. (2018).  Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms. Journal of Clinical Epidemiology. 93, 9 - 24.
Andreadis, P., Karagiannis T., Malandris K., Avgerinos I., Liakos A., Manolopoulos A., et al. (2018).  Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes, Obesity and Metabolism.
Andreadis, P., Karagiannis T., Malandris K., Avgerinos I., Liakos A., Manolopoulos A., et al. (2018).  Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis.. Diabetes Obes Metab. 20(9), 2255-2263.
Vlachaki, E., Gavriilaki E., Kafantari K., Adamidou D., Tsitsikas D., Chasapopoulou E., et al. (2018).  Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.. Hemoglobin. 42(5-6), 339-341.
2019
Kalymniou, M., Dimitriadou M., Slavakis A., Tsapas A., Galli-Tsinopoulou A., & Christoforidis A. (2019).  Decreased cortisol response to low-dose Synacthen test in pediatric patients with type 1 diabetes.. J Diabetes. 11(9), 773-774.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.